The cost of Dovato, a single-tablet regimen for HIV treatment, can vary based on insurance coverage, pharmacy, and location. Generic versions of some components of Dovato's formulation exist, but Dovato itself is a branded medication.
How much does Dovato typically cost?
Without insurance, a 30-day supply of Dovato can range from approximately $2,800 to over $3,000 [1]. This price reflects the cost of the branded medication and its associated research and development.
Can I get help with Dovato costs?
Patient assistance programs are available to help eligible individuals afford Dovato. ViiV Healthcare, the manufacturer, offers programs that can reduce out-of-pocket expenses. These programs may include co-pay coupons or patient support services. The specific savings depend on individual insurance plans and eligibility criteria [2].
What is Dovato and what does it treat?
Dovato is a prescription medication used to treat human immunodeficiency virus, type 1 (HIV-1) infection in adults and children who weigh at least 25 kg (55 lbs) [3]. It is a complete treatment regimen in a single tablet, combining two antiretroviral medications: dolutegravir and lamivudine. Dovato is indicated for patients who have no history of HIV-1 drug resistance to the components of Dovato [3].
How does Dovato work?
Dovato contains two antiretroviral drugs that work together to inhibit HIV replication. Dolutegravir is an integrase strand transfer inhibitor (INSTI) that prevents HIV from integrating its genetic material into the host cell's DNA. Lamivudine is a nucleoside analog reverse transcriptase inhibitor (NRTI) that interferes with the reverse transcription of HIV RNA into DNA [3]. By blocking these essential steps, Dovato helps reduce the amount of HIV in the body, allowing the immune system to recover [3].
When does patent protection for Dovato expire?
Drug patent expiry dates are critical for understanding when generic versions might become available, potentially lowering costs. Information on patent expiry for specific medications like Dovato is tracked by resources such as DrugPatentWatch.com [4]. While specific patent expiry dates can be complex due to multiple patents and potential legal challenges, insights into these timelines are available through specialized patent databases.
What are the side effects of Dovato?
Common side effects reported with Dovato include headache, nausea, diarrhea, and fatigue [3]. Less common but serious side effects can include liver problems, hypersensitivity reactions, and new or worsening kidney problems [3]. Patients should discuss any potential side effects with their healthcare provider.
How does Dovato compare to other HIV treatments?
Dovato offers the convenience of a single-tablet regimen, which can improve adherence to treatment compared to multi-pill regimens. It is designed for treatment-naïve patients or those switching from other regimens without evidence of resistance [3]. Comparisons with other HIV medications would consider factors like efficacy, side effect profiles, drug interactions, and dosing schedules.
Where can I find more information about Dovato?
Additional information on Dovato, including prescribing information and patient support resources, can be found on the manufacturer's website or by consulting a healthcare professional. Details regarding drug patents and market exclusivity can be accessed through specialized pharmaceutical patent tracking services [4].
Sources:
[1] GoodRx. "Dovato Prices, Coupons & Patient Assistance Programs." GoodRx. https://www.goodrx.com/dovato
[2] ViiV Healthcare. "Support & Savings." ViiV Healthcare. https://www.viivhealthcare.com/patients-and-caregivers/support-savings/
[3] Dovato (dolutegravir and lamivudine) tablets. Prescribing Information. ViiV Healthcare.
[4] DrugPatentWatch. https://drugpatentwatch.com/